NextCell Pharma AB Stock Nasdaq Stockholm
Equities
SE0009723125
Biotechnology & Medical Research
Sales 2022 | 6.23M 571K | Sales 2023 | 13.96M 1.28M | Capitalization | 124M 11.35M |
---|---|---|---|---|---|
Net income 2022 | -34M -3.12M | Net income 2023 | -39M -3.57M | EV / Sales 2022 | 19.5 x |
Net cash position 2022 | 97.12M 8.9M | Net cash position 2023 | 50.03M 4.59M | EV / Sales 2023 | 5.28 x |
P/E ratio 2022 |
-6.32
x | P/E ratio 2023 |
-3.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 60.15% |
Managers | Title | Age | Since |
---|---|---|---|
Mathias Svahn
CEO | Chief Executive Officer | 48 | 14-03-18 |
Edvard Smith
FOU | Founder | 73 | 14-03-18 |
Patrik Fagerholm
DFI | Director of Finance/CFO | 57 | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 83 | 13-12-31 | |
Founder | 74 | 14-03-18 | |
Edvard Smith
FOU | Founder | 73 | 14-03-18 |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+46.62% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |